The development of scaffold materials, such as nanoporous and nanofibrous hydrogel for biomedical applications, using green processes is a desirable approach.
Natural biopolymers have been utilized for wound dressing, owing to their bioactive compounds content, mechanical properties, biodegradability, porosity, and proper surface chemistry.
What is Silk Waste?
Silk waste includes different types of raw silks that are unwindable. Even though the composition of silk waste is very much similar to that of good silk, it cannot be utilized for the production of silk textiles.
Typically, silk waste is composed of silk fibroin (SF) core polymer (75−83%) and a sericin glue-like protein as a coating (17−25%).
SF is a natural protein of semi-crystalline structure which provides robust stiffness and impressive strength to silk.
SF has been utilized in various healthcare and biomedical products because of its biodegradability, good mechanical property, biocompatibility with human tissue, flexible morphology, drug permeability, antioxidant and hypolipidemic properties, and nontoxicity.
The US Food and Drug Administration (FDA) has approved SF protein from Bombyx mori silkworm for biomedical purposes.
Production of Polymeric Nanofibers by Electrospinning Method
Electrospinning is one of the most popular, simple, and scalable techniques used for producing polymeric nanofibers used for wound dressing.
Scientists have found that binary blends of SF with other materials enhance the properties of resultant scaffolds, due to the synergistic influence of both components.
Interestingly, the physiochemical properties of nanofibers can be controlled by optimizing the electrospinning parameters to attain the requirements of specific applications.
Typically, organic solvents are used in the electrospinning process due to their high dipole moment, conductivity, dielectric constant, and low surface tension. However, the majority of the organic solvents, such as dichloromethane, formic acid, and hexafluoroisopropanol (HFIP), are toxic.
Very few reports are available on the production of SF nanofiber materials via electrospinning process based on SF/poly(vinyl alcohol) (PVA) and SF/ poly(ethylene oxide) (PEO) in water and water/methanol systems.
However, scientists reported that the fabricated SF nanofibers are sensitive to moisture and can dissolve in the biological system before utilization.
Development of Strong Silk-Fibroin/Poly(ethylene oxide) Non-woven Nanofibers – A New Study
Generally, electrospun processes require some additives to stabilize the nanofibers after their synthesis. However, previous studies have indicated that these additives account for biological risks when used for biomedical purposes.
The new study reported on the development of an additive-free system that involves partial evaporation of the initial solving agent, which is followed by methanolic treatment to enhance the structural morphology.
The additive-free system also aids in improving the mechanical properties of the fabricated nanofibers.
Cross-linking techniques enable the nanofibrous materials to maintain the porosity and stability of the structure.
The radiation-induced crosslinking technique is known to be a green process for the production of hydrogel or scaffold. This is because the entire process, i.e., from the sample preparation to processing, is performed under liquid or solid-state.
The irradiation method utilizes γ-rays or electron beams (EBs) for sterilization of biomedical materials and production hydrogels with wide-ranging applications.
In the new study, scientists explored a dual green route to obtain strengthened SF-based nonwoven nanofibers using pure water for electrospinning and EB-assisted cross-linking technique.
For the fabrication of SF-PEO nanofibers, scientists primarily optimized the electrospinning process using SF/poly(PEO) in a pure water solution for the production of non-woven nanofibers.
Secondly, they focussed on stabilizing the dissoluble SF/ PEO non-woven nanofibers via cross-linking networks developed by a free radical reaction using EB irradiation.
Scientists revealed that this newly designed process lead to the production of cylindrical-shaped, smooth, and elongated SF-PEO nanofibers with a diameter of 169 ± 5 nm, under moderate conditions.
To achieve maximum stability in the fabricated nanofibers, the authors optimized the EB irradiation dose to be 25 kGy for cross-linking, and ~50% gel fraction.
The optimized conditions significantly improved the mechanical properties of the SF/PEO nanofiber.
The tensile strength and elongation at break were augmented and the ductility was increased approximately 22-fold.
Benefits of Silk-Fibroin/Poly(ethylene oxide) Non-woven Nanofibers
The authors reported that cross-linked SF/PEO nanofibers supported cell proliferation and were found to be non-toxic to skin fibroblast cells.
This strongly implies that this nanofiber material could be used for healthcare and biomedical purposes.
One of the important contributions of this study has been the utilization of the 3G strategy, i.e., green electrospinning, green EB irradiation process, and green renewable polymers (silk waste), for the production of non-toxic, strong, stable nanofibers, ideal for wound dressings.
Additionally, the swelling and water absorption property of the SF-PEO nanofiber could be utilized for drug entrapment and controlled release application.
News
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
